MELBOURNE, Australia & NEW YORK–(BUSINESS WIRE)–Fluence Corporation Limited (ASX:FLC) (“Fluence” or the “Company”), a global leader in water and wastewater treatment solutions, today announced that it has successfully produced the first Membrane Aerated Biofilm Reactor (MABR) module in its newly-built production facility in Changzhou, Jiangsu Province, China.
The spiral production line was developed and tested in Israel with all required machinery and equipment shipped and successfully installed in the Changzhou facility. The plant is now fully operational and ready for the mass production of MABR modules.
The first spirals and the first MABR module (comprising 2 spirals) from the plant have been produced. The Company intends to ramp production capacity in the coming months to meet growing market demand in China. The planned capacity of the first production line is 7,500 MABR modules annually, which corresponds to approximately US$75 million (A$100 million) in potential annual sales.
The Changzhou facility has the planned capacity to produce up to 2,500 CMABR units each year. To ensure the high quality of each MABR module and CMABR unit produced, a sophisticated semi-automated test station is now operating to test each unit as it is manufactured at the Changzhou plant.